CRBU plunges 35% premarket after firm scraps CAR‑T; CRH announces small Nordic acquisition

Caribou Biosciences (CRBU) — confirmed crash

Headline: “CRBU Stock Crashes 35% Premarket — RBC Slashes Target By 90% After Caribou Scraps CAR‑T Programs” (published 2026‑10‑07 10:49:26 GMT). Facts: multiple outlets flagged a ~35% premarket decline; RBC reportedly cut its target by about 90% following Caribou’s decision to scrap its CAR‑T programs. Other coverage notes steep share weakness without a concurrent earnings release or new clinical dataset. Time stamps reflect premarket/after‑hours headlines cited in the news digest.

CRH — acquisition announced

Headline: “CRH to Acquire Aggregate Operations in Denmark and Finland” (published 2026‑10‑07 06:27:37 +0000). Facts: CRH issued an acquisition announcement covering aggregate operations in Denmark and Finland; this is a corporate acquisition disclosure (no price or market reaction provided in the available market data).

Uncertainty

News items are drawn from the supplied headlines and timestamps; verify live exchange quotes and company filings for execution prices, definitive deal terms, or further corporate disclosures.

Sources

SMC recent/news digest entries (2026‑10‑07) cited above.

What remains uncertain

• Headlines report time (after‑hours vs premarket) and summary details come from aggregated news market data — confirm live quotes and official filings for trade execution or deal terms.